In general, ex-vivo analysis of organs and tumor masses explanted after 96 h confirmed the presence of the labelled antibodies in the tumor masses and in the liver, suggesting hepatic clearance of the injected IgM (Fig. 3B). The gene discussed is CD40LG; the disease is neoplasm.